AgeX Therapeutics, Inc. (AGE)

Operating Expenses

$25.66M

TTM · Period ending: · USD

AGE logo

AGE Operating Expenses

Latest reported$25.66M
AGE TTM Operating Expenses ($12.28M → $25.66M)
High-resolution chart · PNG

AGE operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AgeX Therapeutics, Inc. Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
25,663,000
24,574,000
24,152,000
26,751,000
25,685,000
23,907,000
20,375,000
15,151,000
12,194,000
10,167,000
10,008,000
8,215,000
7,400,000
7,107,000
6,996,000
7,100,000
7,242,000
7,874,000
8,164,000
9,185,000
10,277,000
11,051,000
12,381,000
12,653,000
13,506,000
14,272,000
14,043,000
14,348,000
13,293,000
12,043,000
12,277,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.